A Proximal Culture Method to Study Paracrine Signaling Between Cells

Summary

Paracrine and juxtacrine cellular interactions play an important role in many biological processes, including tumor progression, immune responses, angiogenesis, and development. Here, a proximal culture method is used to study paracrine signaling where the localized concentrations of the secreted factors are maintained while preventing direct cellular contact.

Abstract

Intercellular interactions play an important role in many biological processes, including tumor progression, immune responses, angiogenesis, and development. Paracrine or juxtacrine signaling mediates such interactions. The use of a conditioned medium and coculture studies are the most common methods to discriminate between these two types of interactions. However, the effect of localized high concentrations of secreted factors in the microenvironment during the paracrine interactions is not accurately recapitulated by conditioned medium and, thus, may lead to imprecise conclusions. To overcome this problem, we have devised a proximal culture method to study paracrine signaling. The two cell types are grown on either surface of a 10 µm-thick polycarbonate membrane with 0.4 µm pores. The pores allow the exchange of secreted factors and, at the same time, inhibit juxtacrine signaling. The cells can be collected and lysed at the endpoint to determine the effects of the paracrine signaling. In addition to allowing for localized concentration gradients of secreted factors, this method is amenable to experiments involving prolonged periods of culture, as well as the use of inhibitors. While we use this method to study the interactions between ovarian cancer cells and the mesothelial cells they encounter at the site of metastasis, it can be adapted to any two adherent cell types for researchers to study paracrine signaling in various fields, including tumor microenvironment, immunology, and development.

Introduction

The role of productive reciprocal interactions between cancer cells and the tumor microenvironment in tumor progression has been well established and has become a major focus of research in cancer biology¹. Similar instances of bidirectional signaling are crucial during wound healing, immune responses, angiogenesis, stem cell niches, and during development^{2,3,4,5,6,7,8}. A common theme in all these biological processes is that cells respond in various ways to extracellular cues from their microenvironment which determine cell fate, tissue physiology, and disease progression. Therefore, the focus has increasingly turned toward developing a better understanding of the mechanisms involved in such cell-cell communications. A majority of such interactions involve paracrine or juxtacrine signaling between cells. Paracrine signaling involves the secretion of specific signaling factors by one cell which are perceived by corresponding receptors on another cell in the vicinity, triggering a response in it^9,10, whereas juxtacrine signaling requires direct contact between cellular components of the two cells involved^11,12.

Such signaling is a crucial component in tissue homeostasis, as well as in the tumor microenvironment. The cancer cells benefit from paracrine and juxtacrine factors from cells in the tumor stroma, including cancer-associated fibroblasts (CAFs), immune cells, and adipocytes^13,14,15,16. The paracrine signaling can be mediated by growth factors, cytokines, chemokines, etc., while the juxtacrine signaling involves juxtaposed ligands and receptors as in Notch signaling, or interactions between integrins and their respective extracellular matrix proteins. We have demonstrated the importance of reciprocal interactions between ovarian cancer cells and CAFs in tumor progression and metastasis¹⁴. Similarly, the interactions of metastasizing ovarian cancer cells with the mesothelial cells covering the site of metastasis regulate key microRNAs and transcription factors in the cancer cells which promote metastatic colonization^17,18.

Most studies on paracrine signaling involve the use of a conditioned medium collected from one cell type to treat the second cell type with. While this approach has been widely used, it does not effectively replicate the localized high-concentration levels of the secreted factor in the microenvironment of the receiving cell. It also fails to reproduce the kinetics of the continuous flow of the secreted factor being produced by one cell and received by the neighboring cell. Paracrine signaling is effective over short distances as the secreted factors are at the required concentrations only in the vicinity of the source cell and tend to diffuse and dilute out as the distance increases. This localized high concentration of the secreted factor is essential to trigger a response in the receptor cell. Moreover, the response in the recipient cells is also dependent on the balance of newly secreted factors and their continuous depletion through degradation, binding, and internalization in the recipient cells and diffusion away from the source cell. Conditioned medium can be concentrated to account for the higher localized concentrations present in the microenvironment, but that cannot accurately replicate the exact concentrations. Moreover, it cannot mimic the natural kinetics of production and depletion of the factor involved. To more accurately replicate paracrine signaling and separate it from juxtacrine signaling mechanisms, we have devised a novel proximal culture method, which involves growing the two cell types on either surface of a porous membrane. The pores are small enough to prevent juxtacrine interactions and yet allow the exchange of secreted factors at localized high concentrations. In that way, this system retains the kinetics of production and depletion of the paracrine factors.

Protocol

The protocol follows the guidelines of the Institutional Regulatory Board of Indiana University.

1. Cell Preparation

1. Isolation and culture of human primary mesothelial cells
   1. Isolate human primary mesothelial cells (HPMCs) from human omentum as described previously^17,18 and grow them in complete growth medium [Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum, 1% penicillin-streptomycin, 1% non-essential amino acids, and 1% vitamins] at 37 °C and 5% CO₂.
      NOTE: The HPMCs are typically grown to 100% confluence (Figure 1A).
2. Growth conditions of ovarian cancer cells
   1. Grow HeyA8 ovarian cancer cells in complete growth medium at 37 °C and 5% CO₂.
      NOTE: Use HeyA8 cells grown to about 80% confluence (Figure 1B).

2. Cell Culture

1. Proximal culture set-up
   1. Use Transwell inserts for 6-well plates with a 10 μm-thick tissue-culture-treated polycarbonate membrane with 0.4 μm pores (10⁸ pores/cm²) and a 4.67 cm² growth area. If needed, optimize for different insert sizes by scaling the number of cells seeded according to the growth surface area. Warm complete growth medium, trypsin, and phosphate-buffered saline (PBS) to 37 °C before use.
2. Preparing the inserts
   1. To seed the HeyA8 cells on the lower surface of the membrane of the insert, remove the insert from its packaging using sterile forceps and place it inverted in a sterile 15 cm culture dish.
   2. Use a 15 cm dish, as it has the depth to accommodate the inverted insert, or substitute it with any appropriate sterile container. Depending on the experiment, place the required number of inserts in the 15 cm dish.
   3. Label the three controls and three experimental conditions accordingly with a marker on the edge of the inserts.
3. Preparing the cancer cells
   1. To trypsinize the HeyA8 cells grown at 80% confluence in a 25 cm² flask (~2 x 10⁶ cells), add 1 mL of trypsin (0.25%) for 40–60 s and neutralize the trypsin with 6 mL of complete growth medium.
   2. Centrifuge the cells at 500 x g at room temperature (RT) for 3 min, discard the supernatant, and resuspend the cell pellet in 5 mL of complete growth medium. Count the live cells using the trypan blue dye exclusion method.
4. Seeding the cancer cells
   1. Suspend 100,000 cells/mL of live HeyA8 cells in complete growth medium. Carefully seed 80,000 HeyA8 cells suspended in 800 μL of complete growth medium on the bottom of the insert (which is now facing up, since it is inverted).
   2. Seed the cells to form a dome-like shape so the cells remain on the insert (Figure 1C). Start from the center of the membrane and move outward in concentric circles while slowly pipetting. Avoid going more than 3 mm from the edge to prevent any spilling of the medium.
      NOTE: The number of cells seeded will depend on the growth rate of the cells and the duration of the experiment. The number of HeyA8 cells seeded for this proximal culture were optimized and the cells will be 80–90% confluent at the end of the third day.
5. Cancer cell attachment
   1. Cover the 15 cm dish and carefully move the dish containing the inserts to the CO₂ incubator. It is critical not to disrupt the drop of medium and cells on the insert at this step. Leave the cells at 37 °C for 4 h to allow the cancer cells to attach to the insert.
6. Preparing the mesothelial cells
   1. After around 4 h, trypsinize the HPMCs grown at 100% confluence in a 75 cm² flask (~4 x 10⁶ cells) with 2 mL of trypsin (0.25%) for 1–2 min and neutralize the trypsin with 12 mL of complete growth medium.
   2. Centrifuge the cells at 500 x g at RT for 3 min, resuspend the cell pellet in 10 mL of complete growth medium, and count the live cells using the trypan blue dye exclusion method.
7. Seeding the mesothelial cells
   1. Suspend 300,000 cells/mL of live HPMCs in complete growth medium. Add 2.5 mL of fresh complete growth media to each well of a 6-well plate. Carefully bring the 15 cm dish containing the inserts out to the biosafety hood. Using sterile forceps, flip the insert and place it in the well of the 6-well plate so that it is upright, with the HeyA8 cells attached to the lower surface immersed in the complete growth medium (Figure 1C).
   2. Seed 450,000 HPMCs suspended in 1.5 mL of growth medium in the inside of the inserts with the HeyA8 cells attached to the surface facing the bottom of the well (Figure 1C) or to inserts without any HeyA8 cells for the HPMC controls. Add 1.5 mL of growth medium without cells to the HeyA8 controls.
8. Growing the proximal culture
   1. Let the proximal culture grow in the CO₂ incubator at 37 °C and 5% CO₂ for 72 h. If required, the medium can be replenished as follows.
      1. For the inside of the insert, remove 750 µL and add 750 µL of fresh complete growth medium.
      2. For the outside of the insert (the 6-well plate), remove 1 mL and add 1 mL of fresh complete growth medium. The 1 mL was chosen for the convenience of changing the medium in one step. If desired, 1.25 mL can be removed and replaced instead.
9. Collecting the cells
   1. Collect the cells after 72 h of proximal culture. Take special care at this step to prevent cross-contamination of the HeyA8 cells and HPMCs. Trypsinize the cells, centrifuge them, and lyse the pellet instead of lysing the cells on the membrane to prevent a cross-contamination.
10. Trypsinizing the cells
    1. Rinse both sides of the insert with 1x PBS.
    2. Transfer the inserts to a new well and add trypsin. Add 0.5 mL of trypsin to the inside of the insert and add 2 mL of trypsin to the 6-well plate to trypsinize the cancer cells attached to the lower surface of the insert. Incubate the plate for 2 min at 37 °C.
11. Neutralizing the trypsin
    1. Add 1 mL of complete growth medium to the inside of the insert to neutralize the trypsin, pipette up and down, and then take the cells and transfer them to a labeled collection tube. Add an additional 2 mL of complete growth medium for a complete neutralization. Care should be taken not to pierce the membrane while pipetting to prevent a cross-contamination of the cells.
    2. To collect the cells on the bottom of the insert, pipette the 2 mL trypsin that was added in step 12.2 onto the bottom surface 2–3x so that the cells fall into the bottom of the 6-well plate. Neutralize the trypsin on the bottom of the plate with 6 mL of growth medium and transfer the contents of the plate to a labeled collection tube.
12. Collecting and lysing the cells
    1. Centrifuge the cells at 500 x g for 3 min and aspirate the media. Resuspend and lyse the cell pellets with 0.7 mL of phenol- and guanidine-thiocyanate-based lysis reagent for the RNA extraction. Isolate the RNA using any suitable kit.

3. Quantitative Real-time Polymerase Chain Reaction

NOTE: The following steps describe a quantitative real-time polymerase chain reaction (qPCR) to study the gene expressions changes as a result of the proximal culture.

1. Prepare cDNA from the RNA samples for qPCR. Use any suitable reverse transcriptase with a corresponding buffer and random primers to ensure the reverse transcription of all mRNA (see Table of Materials).
2. Assess the changes in the mRNA expression levels of fibronectin (FN1) and E-cadherin (CDH1) and transform growth factor beta 1 (TGFβ1) by qPCR with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control. It is possible to use standardized commercially available gene expression assays (see Table of Materials) or to design primers.
3. Compare the HeyA8 cells grown in proximal culture with HPMCs with the HeyA8 controls and the HPMCs grown in proximal culture with the HPMC controls.

Results

Metastasizing ovarian cancer cells encounter mesothelial cells at the site of metastasis within the peritoneal cavity¹⁹. Productive paracrine and juxtacrine interactions with the mesothelial cells help in inducing adaptive responses in the ovarian cancer cells, which enable successful metastasis^17,18,20,21. To test the effectiveness of th...

Discussion

Understanding the mechanism of paracrine and juxtacrine signaling between cells is essential for developing a better knowledge of normal tissue homeostasis and disease conditions^7,8. Most paracrine signaling studies are conducted by collecting conditioned medium from one cell type and using it to treat the other cell type. This method has an advantage in its inherent simplicity. However, it does not accurately recapitulate the localized concentrations of the secr...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
24 mm Transwell permeable support with 0.4 µm Pore Polycarbonate Membrane Insert	Corning (Costar)	3412	• 10 µm thick translucent polycarbonate membrane • Treated for optimal cell attachment • Packaged 6 inserts in a 6 well plate, 4 plates per case • Membrane must be stained for cell visibility • Sterilized by gamma radiation
6 well plate	Corning (Falcon)	353046	Flat Bottom, TC-treated, sterile, with Lid
15 cm culture dish	Corning (Falcon)	353025	Sterile, TC-treated Cell Culture Dish
DMEM	Corning (Cellgro)	10-013-CV
Penicillin Streptomycin	Corning	30-002-CI
MEM Nonessential amino acids	Corning (Cellgro)	25-025-CI
MEM Vitamins	Corning (Cellgro)	25-020-CI
0.25% Trypsin, 2.21 mM EDTA	Corning	25-053-CI
Fetal bovine serum	Atlanta Biologicals	S11150
Pipets			Any make is fine
CO2 Incubator			Any make is fine
Biosafety level II cabinet			Any make is fine
FN1 TaqMan Gene Expression Assay	ThermoFisher Scientific	Hs01549976_m1
TGFB1 TaqMan Gene Expression Assay	ThermoFisher Scientific	Hs00998133_m1
CDH1 TaqMan Gene Expression Assay	ThermoFisher Scientific	Hs01023895_m1
GAPDH TaqMan Gene Expression Assay	ThermoFisher Scientific	Hs99999905_m1
miRNeasy mini RNA isolation Kit	Qiagen	217004
High-Capacity cDNA Reverse Transcription Kit	ThermoFisher Scientific	43-688-13
HeyA8 ovarian cancer cells	Obtained from Ernst Lengyel Lab, University of Chicago
TGFβ Neutralizing Antibody	R&D Systems	MAB1835-100